Revolution medications provide preliminary data from the Zoldonrasib (RMC-9805) in patients with Kras G12D at the annual meeting of 2025 AACR
[og_img]
Source link
Revolution medications provide preliminary data from the Zoldonrasib (RMC-9805) in patients with Kras G12D at the annual meeting of 2025 AACR
[og_img]
Source link